Form 6-K Rosetta Genomics Ltd. For: Nov 05

�

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

�

Form 6-K

�

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

�

For the month of November 2014

�

Commission File Number 001-33042

�

ROSETTA GENOMICS LTD.

(Translation of registrant’s name into English)

�

10 Plaut Street, Science Park

Rehovot 76706, Israel

(Address of Principal Executive Offices)�

�

�

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F � �������������Form 40-F o

�

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): � � � � o

�

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): � � � � o

�

�

�

�

Rosetta Genomics Ltd.

�

On November 5, 2014, Rosetta Genomics, Ltd. (“Rosetta”) convened its previously announced Annual General Meeting of Shareholders (the “Annual Meeting”). However, the quorum of two or more shareholders present, personally or by proxy, who hold or represent together more than 25% of the voting rights of Rosetta’s issued share capital required to conduct the Annual Meeting was not present. Accordingly, pursuant to Rosetta’s articles of association, the Annual Meeting has been adjourned to November 12, 2014. The adjourned Annual Meeting will be held at Rosetta’s offices at 10 Plaut St., Rehovot, Israel at 10:00 a.m. (ET). At the adjourned Annual Meeting, any two shareholders present in person or by proxy shall constitute a quorum.

�

�

�

Signatures

�

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

�

�

�	ROSETTA GENOMICS LTD.
�
� Date: November 5, 2014	By:	/s/ Oded Biran	�
�	�	Oded Biran General Counsel and Secretary	�

�

�

�

�

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• 420 with CNW — Study Enumerates Therapeutic Effects, Quality of Life Benefits of Medical Cannabis
• USCB Financial Holdings, Inc. Reports Diluted EPS of $0.23 for Q1 2024 and Announces Adoption of New 500,000 Share Repurchase Program
• Inspirato to Announce First Quarter 2024 Results Tuesday, May 7